Ads
related to: rifaximin 550 mg- Understanding IBS-C
See The Impact IBS-C Has
On Many Adults. Visit Our Website
- Safety Information
Important Safety Information
And Possible Adverse Effects
- Mechanism Of Action
View MOA Information To See
How This Treatment Works
- Copay Card
See How Much Your Adult Patients
Could Save With This Treatment
- Peer Perspectives
Learn About This Treatment
From Other Gastroenterologists
- Efficacy Data
Clinical Study Design & Results
For This IBS-C Treatment
- Understanding IBS-C
Search results
Results From The WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
XIFAXAN 550 mg is a rifamycin antibacterial indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients ≥ 18 years of age.
Medicare Advantage coverage for Xifaxan Medicare Advantage is a type of health insurance that private companies can offer. Every Medicare Advantage plan must include Original Medicare parts A and B.
A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study.. The antibiotic, rifaximin, has enabled the global ...
In May 2023, Judge Richard G. Andrews upheld the court's original ruling, which blocks the FDA from approving Norwich Pharmaceuticals' 550 mg rifaximin generic until October 2029. Judge Andrews' decision bolsters his previous ruling that Norwich's abbreviated new drug application for rifaximin infringed on Bausch Health's Xifaxan patents for ...
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]